Purapharm Corp. Ltd. | Mutual Funds
Mutual Funds that own Purapharm Corp. Ltd.
Atlantis Intl. Umbrella Fund - China Healthcare Fund
2,815,500
1.13%
-649,000
3.68%
12/31/2017
DFA International Core Equity Portfolio
387,000
0.16%
0
0%
04/30/2018
DFA Asia Pacific Small Company Series
137,000
0.06%
0
0%
01/31/2018
DFA International Vector Equity Portfolio
70,000
0.03%
0
0%
04/30/2018
| Address |
Suite 4002, Jardine House
Hong Kong
Hong Kong
|
|
Employees
|
- |
| Website |
http://www.purapharm.com |
| Updated |
07/08/2019 |
| PuraPharm Corp. Ltd. operates as an investment holding company. It engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. The company operates through the following segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, and Clinics. |
